EcoDrugPlus

Ensembl ID : ENSDLAG00005024075
Gene Symbol: -
Cross references: -
331 Possible Orthologues:

Ensembl ID : ENSDLAG00005027016
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSDLAG00005029712
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSDLAG00005030911
Gene Symbol: -
Cross references: -
128 Possible Orthologues:

Ensembl ID : ENSDLAG00005031853
Gene Symbol: -
Cross references: -
160 Possible Orthologues:

Ensembl ID : ENSDLAG00005031886
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSDLAG00005001678
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSDLAG00005000334
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSDLAG00005004694
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSDLAG00005000313
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSDLAG00005000398
Gene Symbol: -
Cross references: -
217 Possible Orthologues:

Ensembl ID : ENSDLAG00005001891
Gene Symbol: -
Cross references: -
240 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).